Boston Scientific Corporation logo

Boston Scientific Corporation

BSX | NYSE
Chart Builder DCF Calculator
$44.12
+$2.14 (+5.10%)
Nov 2, 2026, 12:03 PM ET · Market open
Fiscal Year
Period Ending
FY 2025
Dec 31, 2025
FY 2024
Dec 31, 2024
FY 2023
Dec 31, 2023
FY 2022
Dec 31, 2022
FY 2021
Dec 31, 2021
FY 2020
Dec 31, 2020
Cash & Equivalents
2.05B 414M 865M 928M 1.93B 1.73B
Short-Term Investments
n/a n/a n/a n/a n/a n/a
Long-Term Investments
842M 555M 413M 407M 412M 918M
Other Long-Term Assets
559M 749M 680M 707M 563M 545M
Receivables
2.93B 2.56B 2.23B 1.97B 1.78B 1.53B
Inventory
2.94B 2.81B 2.48B 1.87B 1.61B 1.35B
Other Current Assets
580M 831M 622M 731M 799M 1.88B
Total Current Assets
8.79B 6.92B 6.51B 5.76B 6.32B 6.69B
Property-Plant & Equipment
4.5B 3.74B 3.3B 2.83B 2.69B 2.54B
Goodwill & Intangibles
25.3B 23.77B 20.39B 18.82B 18.11B 15.87B
Total Long-Term Assets
34.88B 32.48B 28.62B 26.71B 25.91B 24.08B
Total Assets
43.67B 39.4B 35.14B 32.47B 32.23B 30.78B
Account Payables
1.14B 960M 942M 862M 794M 513M
Deferred Revenue
313M 306M 266M 220M 208M 138M
Short-Term Debt
389M 1.78B 531M 20M 261M 13M
Other Current Liabilities
2.17B 491M 1.92B 1.64B 629M 1.17B
Total Current Liabilities
5.44B 6.4B 4.93B 3.8B 4.27B 3.68B
Long-Term Debt
11.46B 8.84B 8.57B 8.91B 8.8B 9.12B
Other Long-Term Liabilities
1.14B 1.14B 1.27B 1.4B 1.55B 1.66B
Total Long-Term Liabilities
13.76B 10.99B 10.67B 11.09B 11.33B 11.77B
Total Liabilities
19.2B 17.39B 15.61B 14.9B 15.61B 15.45B
Total Debt
12.42B 11.15B 9.49B 9.28B 9.45B 9.54B
Book Value
24.47B 22B 19.53B 17.57B 16.62B 15.33B
Book Value Per Share
16.37 14.81 13.34 12.21 11.59 10.82
Common Stock
17M 17M 17M 17M 17M 17M
Retained Earnings
5.57B 2.67B 819M -750M -1.39B -2.38B
Comprehensive Income
-610M 275M 49M 269M 263M 207M
Shareholders Equity
24.23B 21.77B 19.28B 17.57B 16.62B 15.33B
Total Investments
842M 555M 413M 407M 412M 918M

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.